InhaleRx Limited (ASX:IRX) Executes Study Order for Phase 2 IRX-211 Trial
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.
Thor Energy PLC (ASX:THR) converts its licence to an RSEL, advancing hydrogen and helium exploration projects.
ACCC raises concerns over DP World Australia’s proposed acquisition of Silk Logistics Holdings Limited (ASX:SLH), evaluating potential competition impacts.
Ionic Rare Earths (ASX:IXR) reports up to 61% lower CO₂ emissions from its magnet recycling process and launches MagNetZero TM initiative.
Sarytogan Graphite (ASX:SGA) advances water drilling efforts in Kazakhstan to secure essential water supply for its graphite project.
Element 25 Limited (ASX:E25) secures final regulatory approval for the Butcherbird Expansion Project, enabling the development of a 1.1Mtpa manganese production facility.
Norwest Minerals (ASX:NWM) secures State Deed approval for Bulgera Gold Project, advancing towards formal mining lease.
Nickel Industries Limited (ASX:NIC) explains recent stock price decline and increased trading volume due to a block share sale and regulatory proposals.
Metal Powder Works Limited (ASX:MPW) trading suspension is lifted as the company complies with ASX Listing Rules.
InFocus Group Holdings Limited (ASX:IFG) secures AUD 172,125 in placement commitments, totaling $422,125 for working capital and client projects.